• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痉挛性发声障碍:综述。第1部分:致病因素。

Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors.

作者信息

Hintze Justin M, Ludlow Christy L, Bansberg Stephen F, Adler Charles H, Lott David G

机构信息

1 Head and Neck Regeneration Program, Center for Regenerative Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.

2 Department of Communication Sciences and Disorders, James Madison University, Virginia, USA.

出版信息

Otolaryngol Head Neck Surg. 2017 Oct;157(4):551-557. doi: 10.1177/0194599817728521. Epub 2017 Aug 29.

DOI:10.1177/0194599817728521
PMID:28850801
Abstract

Objective The purpose of this review is to describe the recent advances in identifying possible factors involved in the pathogenesis of spasmodic dysphonia. Spasmodic dysphonia is a task-specific focal laryngeal dystonia characterized by irregular and uncontrolled voice breaks. Pathogenesis of the disorder is poorly understood. Data Sources PubMed, Google Scholar, and Cochrane Library. Review Methods The data sources were searched using the following search terms: ( spasmodic dysphonia or laryngeal dystonia) and ( etiology, aetiology, diagnosis, pathogenesis, or pathophysiology). Conclusions Several potential etiological factors have been proposed by epidemiological, genetic, and neuropathological studies. Spasmodic dysphonia is a rare disorder primarily affecting females beginning in their 40s. Vocal tremor co-occurs in 30% to 60%. Large cohort studies identified risk factors such as a family history of neurological disorders including dystonia and tremor, recent viral illness, and heavy voice use. As none are rare events, a complex interactive process may contribute to pathogenesis in a small proportion of those at risk. Consequences to pathogenesis are neurological processes found in spasmodic dysphonia: loss of cortical inhibition, sensory processing disturbances, and neuroanatomical and physiological differences in the laryngeal motor control system. Implications for Practice Diagnosis of spasmodic dysphonia usually includes speech and laryngoscopic assessment. However, as diagnosis is sometimes problematic, measurement of neurophysiological abnormalities may contribute useful adjuncts for the diagnosis of spasmodic dysphonia in the future.

摘要

目的 本综述旨在描述在确定痉挛性发声障碍发病机制中可能涉及的因素方面的最新进展。痉挛性发声障碍是一种特定任务的局灶性喉肌张力障碍,其特征为声音不规则且不受控制地中断。该疾病的发病机制尚不清楚。

数据来源 PubMed、谷歌学术和考克兰图书馆。

综述方法 使用以下检索词对数据来源进行检索:(痉挛性发声障碍或喉肌张力障碍)以及(病因、病原学、诊断、发病机制或病理生理学)。

结论 流行病学、遗传学和神经病理学研究提出了几种潜在的病因因素。痉挛性发声障碍是一种罕见疾病,主要影响40多岁的女性。30%至60%的患者会同时出现声带震颤。大型队列研究确定了一些风险因素,如包括肌张力障碍和震颤在内的神经系统疾病家族史、近期病毒感染以及过度用嗓。由于这些都并非罕见事件,一个复杂的相互作用过程可能在一小部分有风险的人群中导致发病机制。痉挛性发声障碍中发现的神经学过程对发病机制的影响包括:皮质抑制丧失、感觉处理障碍以及喉运动控制系统的神经解剖学和生理学差异。

对实践的启示 痉挛性发声障碍的诊断通常包括言语和喉镜评估。然而,由于诊断有时存在问题,神经生理异常的测量未来可能有助于痉挛性发声障碍的诊断。

相似文献

1
Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors.痉挛性发声障碍:综述。第1部分:致病因素。
Otolaryngol Head Neck Surg. 2017 Oct;157(4):551-557. doi: 10.1177/0194599817728521. Epub 2017 Aug 29.
2
Spasmodic Dysphonia: A Review. Part 2: Characterization of Pathophysiology.痉挛性发声障碍:综述。第二部分:病理生理学特征
Otolaryngol Head Neck Surg. 2017 Oct;157(4):558-564. doi: 10.1177/0194599817728465. Epub 2017 Aug 29.
3
Movement Disorders and Voice.运动障碍与嗓音
Otolaryngol Clin North Am. 2019 Aug;52(4):759-767. doi: 10.1016/j.otc.2019.03.018. Epub 2019 May 7.
4
Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.痉挛性发声障碍和声带震颤电话筛查工具的验证
J Voice. 2014 Nov;28(6):711-5. doi: 10.1016/j.jvoice.2014.03.009. Epub 2014 Jun 21.
5
Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.痉挛性发声障碍和声带震颤症状的识别:专家与非专家评判的比较
J Commun Disord. 2001 Jan-Apr;34(1-2):21-37. doi: 10.1016/s0021-9924(00)00039-3.
6
Spasmodic dysphonia: a laryngeal control disorder specific to speech.痉挛性发声障碍:一种特定于言语的喉部控制障碍。
J Neurosci. 2011 Jan 19;31(3):793-7. doi: 10.1523/JNEUROSCI.2758-10.2011.
7
Spasmodic dysphonia: let's look at that again.痉挛性发声障碍:让我们再看看那个。
J Voice. 2014 Nov;28(6):694-9. doi: 10.1016/j.jvoice.2014.03.007. Epub 2014 Jun 24.
8
Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.内收型痉挛性发声障碍患者的嗓音参数与自我认知
J Voice. 2017 May;31(3):391.e7-391.e18. doi: 10.1016/j.jvoice.2016.09.029. Epub 2016 Nov 17.
9
Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.内镜下激光甲状肌神经切除术治疗内收性痉挛性发音障碍患者:一项关于嗓音质量长期疗效的初步研究。
J Voice. 2012 Sep;26(5):666.e7-12. doi: 10.1016/j.jvoice.2011.07.009. Epub 2011 Sep 22.
10
Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.甲状软骨内收肌肉毒毒素注射治疗伴有声带震颤的痉挛性发声障碍。
J Voice. 2011 Jan;25(1):114-9. doi: 10.1016/j.jvoice.2009.08.003. Epub 2010 Feb 4.

引用本文的文献

1
Association of Laryngeal Dystonia With Common Neurologic Disorders.喉肌张力障碍与常见神经系统疾病的关联。
Laryngoscope. 2025 Jul 9. doi: 10.1002/lary.32407.
2
Laryngeal dystonia and vocal tremor response to botulinum toxin injection.喉肌张力障碍和声带震颤对肉毒杆菌毒素注射的反应。
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):919-926. doi: 10.1007/s00405-024-09111-z. Epub 2024 Dec 7.
3
Transnasal Endoscopic Injection of Botulinum Toxin in Patients with Adductor Spasmodic Dysphonia.经鼻内镜下肉毒杆菌毒素注射治疗内收型痉挛性发声障碍患者
Iran J Otorhinolaryngol. 2024 Sep;36(5):595-601.
4
Transcriptome Analysis of Left Versus Right Intrinsic Laryngeal Muscles Associated with Innervation.与神经支配相关的左侧与右侧喉内肌的转录组分析
Laryngoscope. 2024 Aug;134(8):3741-3753. doi: 10.1002/lary.31487. Epub 2024 May 9.
5
Demographic and clinical characteristics of our patients diagnosed with laryngeal dystonia.我们诊断为喉肌痉挛患者的人口统计学和临床特征。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4265-4271. doi: 10.1007/s00405-024-08688-9. Epub 2024 May 7.
6
Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia: a systematic review and meta-analysis.单侧或双侧肉毒毒素注射治疗内收肌痉挛性发音障碍的疗效和不良反应比较:系统评价和荟萃分析。
Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1357-1369. doi: 10.1007/s00405-023-08366-2. Epub 2023 Dec 14.
7
Demographics and Clinical Characteristics Associated with the Spread of New-Onset Laryngeal Dystonia.与新发喉肌张力障碍传播相关的人口统计学和临床特征。
Laryngoscope. 2024 May;134(5):2295-2299. doi: 10.1002/lary.31146. Epub 2023 Nov 1.
8
Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia.年龄和性别在内收型痉挛性发声障碍肉毒杆菌神经毒素剂量中的意义。
World J Otorhinolaryngol Head Neck Surg. 2023 Jan 29;9(2):168-173. doi: 10.1002/wjo2.88. eCollection 2023 Jun.
9
Machine Learning Assessment of Spasmodic Dysphonia Based on Acoustical and Perceptual Parameters.基于声学和感知参数的痉挛性发声障碍的机器学习评估
Bioengineering (Basel). 2023 Mar 28;10(4):426. doi: 10.3390/bioengineering10040426.
10
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.肉毒毒素神经毒素疗法在喉部肌张力障碍的临床治疗中的应用。
Toxins (Basel). 2022 Dec 1;14(12):844. doi: 10.3390/toxins14120844.